The role of vascular cell integrins alpha v beta 3 and alpha v beta 5 in angiogenesis.
Varner
J A
JA
Department of Medicine, University of California, San Diego, La Jolla 92093-0063, USA.
D000818:Animals; D017209:Apoptosis; D001766:Blindness / Q000503:physiopathology; D001808:Blood Vessels / Q000502:physiology; D016228:Endothelial Growth Factors / Q000502:physiology; D016326:Extracellular Matrix Proteins / Q000502:physiology; D005128:Eye Diseases / Q000473:pathology; D005260:Female; D016220:Fibroblast Growth Factor 1 / Q000502:physiology; D016222:Fibroblast Growth Factor 2 / Q000502:physiology; D006801:Humans; D007249:Inflammation; D016023:Integrins / Q000502:physiology*; D016209:Interleukin-8 / Q000502:physiology; D008222:Lymphokines / Q000502:physiology; D008297:Male; D009369:Neoplasms / Q000098:blood supply* / Q000473:pathology; D009389:Neovascularization, Pathologic; D019030:Receptors, Vitronectin / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D016326:Extracellular Matrix Proteins; D016023:Integrins; D016209:Interleukin-8; D008222:Lymphokines; D019030:Receptors, Vitronectin; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C064660:integrin alphaVbeta5; D016222:Fibroblast Growth Factor 2; D016220:Fibroblast Growth Factor 1